GRCE
Grace Therapeutics, Inc. Common Stock
GRCE
GRCE
12 hedge funds and large institutions have $6.36M invested in Grace Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$48.4K |
2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$8.2K |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$51 |